# First choIce Antidepressants: General Practitioner's Treatment Approach in the Czech Republic

> **NCT05291897** · — · TERMINATED · sponsor: **Angelini Pharma Česká republika s.r.o.** · enrollment: 28 (actual)

## Conditions studied

- Major Depressive Disorder Co-Occurrent With Anxiety
- Adult Patients
- Newly Diagnosed Depression

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05291897
- **Lead sponsor:** Angelini Pharma Česká republika s.r.o.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2021-10-15
- **Primary completion:** 2023-06-10
- **Final completion:** 2023-06-30
- **Target enrollment:** 28 (ACTUAL)
- **Why stopped:** The number of needed patients wasn't enrolled
- **Last updated:** 2023-07-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05291897

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05291897, "First choIce Antidepressants: General Practitioner's Treatment Approach in the Czech Republic". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05291897. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*